Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...
The FDA approves a new non-opioid pain pill, Journavx, to treat acute pain in adults. It's a first-generation non-addictive ...
A study has found that a single dose of the Imvanex vaccine provides protection against Mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer ...
The following is a list of major prescription drugs whose ingredients or components are imported into the United States from the European Union, based on U.S. Food and Drug Administration import data ...
Vermont has the second lowest state fatality rate in the US (146.3 per 100K; Hawaii 112.7/100K). Mississippi (462.8/100K) and ...
Buying stocks after they have lost significant market value can lead to excellent returns in the long run, but only if the ...
Pandemic influenza remains a significant global health threat, as signalled by the circulation and cross-species transmission of avian influenza A(H5N1) viruses from the clade 2.3.4.4b, including ...
11d
Investing News Network on MSNBird Flu Vaccine Stocks: 8 Companies Developing H5N1 VaccinesLife science companies developing bird flu vaccines are gaining attention as the avian influenza subtype H5N1 becomes an increasing concern. The United States is in the midst of an H5N1 bird flu ...
13d
BabyCenter on MSNShould babies, toddlers, and older children get the COVID-19 vaccine?With all the different messages and information about the COVID-19 vaccine, you may be wondering whether your little one ...
The Centers for Disease Control and Prevention is initiating expanded research into understanding autism and its potential links with vaccines, a source familiar with the CDC’s planning said.
Decades of scientific evidence haven’t found a link between autism and vaccines, but that doesn’t appear to stop the U.S. Centers for Disease Control and Prevention from reportedly planning to ...
Cadillac has finally received its official approval to join the 2026 Formula 1 grid, ending a year-long drama that started when General Motors and Andretti Global's application was initially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results